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1. Introduction 
As a burgeoning research area, stem cells’ unique self-renewal and multilineage 
differentiation capability have quickly attracted the attention of scientists and researchers 
worldwide. Promising applications of stems cells include repairing and regenerating 
diseased or aged tissues and organs, restoring impaired body functions, and providing new 
treatments to various diseases. 
One member in the stem cell family that deserves special mention is human umbilical cord 
derived mesenchymal stem cells (hUC-MSC). Great clinical application value and broad 
industrial development prospect of hUC-MSC have been recognized due to its large 
differentiation potential, strong proliferation capability, low immunogenicity, source 
variety, convenient availability, free of ethical restriction, and easy production in industry. 
Obviously, these unique features of stem cells rely on various factors including their 
biological composition, structure, and cell viability. The viability decrease, apoptosis, or 
necrosis of stem cells will seriously lead to the variation or even loss of their functions. 
Therefore, a key step in the production and quality control of stem cells is to accurately 
monitor the status of stem cells and their viability in real time. Research in this field has 
shown great importance in not only fundamental study of stem cell biology, but also 
research, development, and clinical use of stem cell drugs. 
Although contemporary cell biology has provided a number of ways to acquire the 
information on the status of the cells, these methods are often invasive. Relevant biochemical 
reactions, dyeing, marking, fixation, cell lysis, and other treatments could remarkably induce 
the change of the environment necessary for cell growth and the normal physiological function 
of the cells. These biological techniques could even destroy the structures of the cells, leading 
to irreversible cell damage or necrosis. As a result, biology-based methods can hardly meet the 
requirements for the production and quality control of stem cells. 
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Raman spectroscopy has prominent advantages over biological methods due to its high 
sensitivity to changes inside biological systems and influences from external environment. 
Also, it plays non-destructively on the cells. These distinguished features make Raman 
spectroscopy a superior choice in the study of high spatial resolution and real time 
monitoring of stem cells.  
In this chapter, we will first introduce the basic concepts and theories of light absorption 
and scattering, and Raman scattering. Then, the change of the stem cell viability and its 
related mechanisms studied by Raman spectroscopy will be described in detail. Finally, a 
summary of our overall work will be given. 
2. Basic concept and elementary theory 
2.1 Scattering and light scattering 
Scattering is a phenomenon widely seen in nature. When the incident particles collide with 
target particles, the incident particles interact with the target particle making the incident 
particles deviating from the incident direction and even changing its energy. This 
phenomenon is known as scattering. Analyzing the interactions of matters and their internal 
structures and movements by scattering has become an important tool in both macro and 
micro worlds. 
Scattering of light is often observed in our daily lives. For example, when the light passes 
through a homogeneous and transparent matter such as glass and water, we cannot notice 
the light path from the side. However, if the media is inhomogeneous or contains impurities 
(like liquid with suspended particles or gels), the light beam can be clearly observed in the 
medium. This results from the scattering of light. 
In the 19th century, the study of light scattering was focused on liquid and gas, which are 
widespread in nature. Based on the causes, the scatterings are classified as Tyndall 
scattering and molecular scattering. British physicist Lord Rayleigh studied the intensities of 
scattered molecular light. In 1871, he proposed that the intensity of scattered light is 
inversely proportional to the fourth powers of the wavelength (ǌ4). He proposed that the 
intensity of scattered light is inversely proportional to the fourth powers of the wavelength, 
which is known as the famous Rayleigh scattering law. In 1908, C. Mie found that the 
intensity of scattered light in Tyndall scattering is not inversely proportional to the fourth 
powers of the wavelength, which is in contrary to molecular scattering. Therefore, Tyndall 
scattering is also called Mie scattering.  
Since the 20th century, the study of light scattering reached deeply into the levels of atoms, 
electrons, and quasi-particles. Researchers began to pay attention to the energy change of 
the scattered light relative to the incident light (i.e., the wavelength change). It was found 
that the wavelength variation of the scattered light relative to the incident light corresponds 
to different scattering mechanisms. The types of light scattering are thus classified. In the 
study of light scattering, the unit of energy is commonly the wave numbers (cm-1) .When the 
wave number change is less than 10-5 cm-1, the scattering is called Rayleigh scattering. Wave 
number change of about 0.1 cm-1 is called Brillouin scattering. More than 1 cm-1 wave 
number change is known as Raman scattering. If the wavelength / energy of the scattered 
light does not change relative to the incident light, it is elastic scattering, otherwise is non-
elastic scattering. Obviously, the latter two types of scattering are non-elastic scattering. The 
wave number change in Rayleigh scattering is caused by the rebound of the target particles, 
and therefore Rayleigh scattering is elastic scattering. 
www.intechopen.com
Raman Spectroscopy for Noninvasive Monitoring of 
Umbilical Cord Mesenchymal Stem Cells Viability Transitions 
 
767 
 
 
Fig.1. Scattering of light 
2.2 Raman scattering 
Raman spectroscopy is a scattering spectroscopy that concerns the vibrational and rotational 
energy levels of the molecules. It is a useful tool for the analysis of molecular structure, with 
advantages of being non-destructive and without the need of special ways to prepare the 
samples. Compared with the infrared absorption spectroscopy, water shows extremely 
weak Raman signals. Thus for most samples in water, the noise from water can be greatly 
reduced. Raman spectroscopy can also record signals from different samples in the same 
time, and these signals do not interfere with each other. With the developments of laser 
technology and weak signal detection technology, Raman spectroscopy as an effective 
method to study the structure of matter, will find wide and practical applications in various 
fields including chemistry, physics, biology, and medicine. 
From the basic perspective of quantum theory, Raman scattering can be considered as an 
inelastic process as a result of the collisions between photons and molecules. When the 
incident photons collide with molecules, molecules interact with the photons and then 
absorb the photon energies. Molecules are thus excited into a virtual state. Since this virtual 
state is not stable, molecules immediately radiate photons and release energy. If the energy 
of the photon radiation is smaller than that of the incident photon, Stokes shift will be 
observed (Fig.2a). If the energy of photon radiation is larger than that of the incident photon, 
anti-Stokes shift will be recorded (Fig.2b). If the energy of photon radiation is equal to that 
of the incident photon, Rayleigh scattering will be produced (Fig.3). Since Raman scattering 
concerns the energy difference between the incident and scattered photons, this energy 
difference is associated with the corresponding vibration levels of the molecules. 
Since each substance has rich vibration levels, Raman spectra carry a lot of information 
about the materials. Known as the fingerprint spectrum, Raman spectroscopy is of great 
significance to the analysis and identification of the components of materials.   
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Fig. 2a. Raman scattering (Stokes effect) 
 
 
 
 
 
Fig. 2b. Raman scattering (Anti-Stokes effect) 
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Fig. 3. Rayleigh scattering 
3. Detecting viability transitions of umbilical cord mesenchymal stem cells by 
Raman micro-spectroscopy 
Mesenchymal stem cells (MSCs) are pluripotent progenitor cells derived from the 
mesoderm. They are particularly attractive in cell/gene therapy for tissue regeneration and 
cancer therapy [1] for their own specific properties, including multi-differentiation potential, 
hematopoietic-supporting activity, immunomodulatory potency, and self-renewal. The 
major source of MSCs is bone marrow. However, the clinical use of bone marrow-derived 
MSCs is limited due to the relatively invasive sample collection procedure, and a significant 
reduction in cell number, proliferation, and differentiation capacity with age or age-related 
diseases. Recent advances suggest that human umbilical cord-derived mesenchymal stem 
cells (hUC-MSCs) could be an alternative source ideal for MSCs due to the relative ease of 
collection, safety, and abundance of human umbilical cord [2-5]. 
Our group has developed a standard procedure to acquire hUC-MSCs and established the 
first hUC-MSCs bank in China. Our intensive studies on the possible clinical application of 
this type of cells suggest that they can work as a promising candidate for cell-based therapy 
because of their young age and low infection rate compared to MSCs in adult tissues [6-9]. A 
large population of hUC-MSCs sustained in high viability condition is fundamental to 
successful cell-based therapy. Therefore, monitoring the cellular state transitions is an 
important step for the population expansion and quality assurance of these cells. 
Currently, a number of methods including biological assays and optical techniques are 
available to handle this task. For example, laser scanning confocal fluorescence microscopy 
has been used to image living cells. However, the introduction of exogenous fluorescence 
labels is always a problem in the cell viability maintenance. On the contrary, Raman 
spectroscopy is a label-free, vibration spectroscopy-based technique that has been used to 
illustrate the intrinsic molecular structure and composition of biological samples. It has the 
potential to provide new and unique optical markers for cytological analysis in recent years 
[10-18]. At the present time, this technique has been increasingly used in the studies of stem 
cells. Notingher et al. monitored the differentiation of embryonic stem cells (ESCs) by 
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recording the intensity of Raman peaks of nucleic acids as differentiation markers [19]. Chan 
et al. demonstrated that cell identification and classification were achieved using Raman 
scattering of the intrinsic biochemical signature for individual human embryonic stem cells 
(hESCs) [20]. More recently, Chiang and co-workers successfully applied Raman 
spectroscopy to monitor and quantitatively evaluate the differentiation of hMSCs into 
osteoblasts [21]. 
Here, the Raman micro-spectroscopy is used to find the molecular vibrations that are 
sensitive to the viability change of hUC-MSCs. The Raman spectra of hUC-MSCs with 
different cellular states were investigated, and the spectral differences between the cells with 
high viability (> 90%) and low viability (< 20%) were quantified using peak fitting and 
statistic t-test. It is found that the Raman peaks at 744, 877, and 1342 cm-1 show the most 
obvious changes as the cell viability decreases: the former two peaks, which correspond 
respectively to the vibration of C=O out-of-the-plane bending in Thymine and the 
symmetric stretching of C-C in lipids, are both roughly doubled; however, the latter peak, 
which corresponds to C-H deformation in proteins, is reduced by ca. 30%. 
4. Experimental   
Isolation and culturing of hUC-MSCs 
hUC tissues were collected from voluntary donors, the healthy parturient women with well-
developed fetus, who signed the consent form informed beforehand. The collection followed 
proper procedures according to the regulations of the Research Ethics Committees of the 
Chinese Academy of Medical Sciences and Beijing Union Medical College. The hUC tissues 
were then minced into 1mm3 small fragments with sharp scissors. The fragments were 
washed thoroughly with PBS to remove contamination, and then treated with 0.075% 
collagenaseII and 0.25% trypsin (Sigma) at 37 oC for 30 min. The digested mixture was 
passed through a 200µm filter to obtain cell suspensions. The dissociated cells were washed 
twice with PBS, planted on uncoated 25cm2 culture flasks, and then cultured in Dulbecco’s 
modified Eagle’s medium with low gluocose (DMEM-LG/F-12, DF12; Gibco) and 10% Fetal 
bovine serum (FBS, USA). The culture medium was replaced 2 days first and then after 
every 3 or 4 days. Daily progress of the cell culturing was monitored by phase-contrast 
microscopy. The cells were serially passaged and expanded in a humidified incubator at 37 
oC with 5% CO2.  
hUC-MSCs with different viability were used for experiments. Decrease of the cell viability 
was induced by placing the cells under a condition of starvation, i.e. suspending in PBS at a 
low temperature of 4 oC for several days. The cell viability was accessed using the Trypan 
blue method in parallel with the Raman spectral measurements. The viability is defined as 
the ratio of the number of viable cells to the total number of all cells, and we call > 90% 
viability as “high viability” while < 20% viability as low viability. 
Raman micro-spectroscopy of hUC-MSCs with different viability 
The Raman spectra of hUC-MSCs with different viability were recorded using a Raman micro-
spectrometer (LabRAM HR800, HORIBA Jobin Yvon, France), which is equipped with a 632.8 
nm helium-neon laser for excitation. By means of the microscopic imaging provided by a TV 
camera, the Raman spectrum of each cell was measured by focusing the laser beam in the 
center of the cell. Under the laser power of 17 mW with a 50× objective, the signal was 
integrated for 100 s. Each Raman spectrum was recorded in the range of 600-1800 cm−1. 
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Spectral processing and statistical analysis 
For spectral preprocessing, the background signal was subtracted from each spectrum, and 
a multipoint baseline was corrected in the whole spectral region. Spectra were then 
normalized to the peak intensity at 1448 cm−1 according to ref. [11] and [20]. 
In order to quantitatively characterize the Raman peaks, peak fitting was carried out in the 
spectral regions that show obvious differences between the cells with high and low viability 
by using the PeakFit software (v4.12, SeaSolve Software Inc., USA). The peak shape was 
taken to be Gaussian.  
To statistically compare the intensity difference peak by peak, the Student’s t-test was 
performed on each fitted Raman peak for two cell-groups (one group of 22 hUCMSCs with 
high viability and the other of 20 with low viability). The p values obtained from the t-test 
are used as the indicators of the differences. Since the p value is defined as the probability of 
making a wrong judgment about a difference between the two sets of data, the smaller p 
value implies the existence of the difference with higher possibility. As a rule of thumb, 
when p<0.05 the difference is meant to be statistical significance. 
5. Experimental results  
Fig. 4 shows the average Raman spectra of hUC-MSCs, where curve “a” is for high viable 
cells and curve “b” for low viable cells. The Raman spectra show small standard deviations 
among the cells with the same viability (as presented as the gray shadows in curve “a” and 
“b”). As can be seen, there are several Raman peaks that are already discernable, i.e. the 
1448 cm−1 peak corresponding to CH deformation, the 1659 cm−1 peak to the protein amide 
I, the 1003 cm−1 peak to the ring breathing of phenylalanine and the 1301 cm−1 peak to lipid 
CH2 twist. Curve “c” plots the subtraction of “b” and “a”, where visible differences can be 
observed, especially in the regions of 617 – 690, 703 – 770, 840 – 945, 950 – 1020, and 1250 – 
1360 cm−1, and at the peak of 1659 cm−1. 
A Raman peak, which is uniquely defined by its spectral parameters including Raman shift, 
intensity, and full width at half maximum (FWHM), reveals the information about a specific 
molecular vibration. In order to extract the Raman peaks in the spectral regions where the 
high viable cells and low viable ones are distinguishing, the peak fitting analysis was 
performed. Fig. 5 shows the fitting results of curve “a” and “b” in Fig.4, and Table 1 
provides the extended peak assignments. 
It can be seen from Fig. 5 that when the cell viability decreases, no obvious changes in 
Raman shift and FWHM are observed. However, the variations in peak intensity can be 
observed clearly. Apparently, as the cell viability decreases, the intensities of peaks at lower 
Raman shift (<1000 cm−1) increase while those of peaks at 1003 and 1342 cm−1 weaken. These 
results indicate that we can choose the peak intensity as a signature for detecting the cell 
viability transitions. As there are several peaks whose intensity change with the cell viability 
decrease, the Student’s t-test is used for picking out the peaks with significant difference 
between the high viable and low viable cells, thus to find the molecular vibrations sensitive 
to the cell viability changes. The result of the t-test is described by the p value, which 
actually reflects a reliability of the difference. Generally, p<0.05 represents a significant 
difference, and the lower the p value is, the more reliable the difference will be. As listed in 
Table 2, there are about half of the peaks having significant differences in peak intensity as 
indicated by p<0.05. The intensity changes of these peaks with p<0.05 are illustrated in Fig. 
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6. When the cell viability decreases, the intensity of peaks corresponding to nucleic acids at 
621, 643, 667, 744, 900, and 1010 cm−1 and to lipids at 719, 877, and 980 cm−1 increase, while 
those assigned to proteins at 1003, 1342, and 1659 cm−1 decrease. Especially, the most 
reliable spectral differences (p<0.001) between the hUC-MSCs with high and low viability 
can be found in the C=O out of plane bending in Thymine at 744 cm−1, C–C symmetric 
stretching in lipids at 877 cm−1, and C–H deformation in proteins at 1342 cm−1. In 
comparison of the case of high viability, the peak intensity of 744 and 877 cm−1 are both 
about doubled while that of 1342 cm−1 reduces by about 30% in the spectra of those with low 
viability. Herein, we suggest that the viability of hUC-MSCs can be characterized by 
intensities of these three peaks. 
As mentioned in this paper, the peak intensity could be a signature for indicating the cell 
viability transitions. And the correlation with the peak intensity and the cell viability has been 
proved by our studies. To understand it further, the possible causes of the peak intensity 
changes are discussed briefly here. As been shown in Table 1, the Raman spectra of hUC-
MSCs are contributed from all major biological macromolecules including nucleic acids, 
proteins, lipids and carbohydrates. The intensity changes of the Raman peaks, especially for 
those highly sensitive to the cell viability transitions, can be understood from the interaction 
model between the intracellular reactive oxygen species (ROS, such as ·OH, O2-, and H2O2, 
which are the products of cell metabolism) and the biological macromolecules. 
In healthy cells, ROS are typically generated at controlled rates. In contrast, the production 
of ROS will be elevated under stress conditions (e.g. cell apoptosis). This elevation will 
result in changes of many cellular components, such as DNA, proteins, and lipids, which 
will lead to further influence on the cell viability, metabolism, and growth. In addition to the 
findings shown in this paper, new research results from our lab on hUC-MSCs show that 
about half of the cells with low viability appear to be apoptotic (these results will be 
published elsewhere). As mentioned above, a large amount of ROS will stack in this 
situation. There were results suggesting that the excessive ROS will introduce attacks on 
intracellular biomolecules such as nucleic acids, proteins, and lipids [26]. So we believe that 
the peak intensity changes can be explained by the effect of excessive ROS, as follows. 
Because excessive ROS destroy the base-base stacking interactions, the hyperchromicity 
occurs resulting in the increasing intensity of Raman peaks, which correspond to nucleic 
acid bases at 744, 667, 643, and 621 cm−1. Moreover, the alterations in spatial structures of 
liposomes will inevitably change the micro-environment and spatial arrangement of 
chemical bonds within the molecular chains, which are probably responsible for the 
intensity variations of the Raman peaks assigned to lipids at 980, 877, and 719 cm−1. For 
proteins, the conformational changes in the secondary structures of proteins, such as the 
reduction of α-helix as indicated by the lower intensity at 1659 cm−1, were observed with as 
the cell viability decreases. These may be attributed to the attack of ROS that can lead to 
impairing or even breaking of hydrogen bonds, disulfide bonds and carbon-sulfur bonds, 
which play important roles in maintaining the structures of proteins. The structure 
variations of proteins are most likely to cause the micro-environmental changes of chemical 
bonds such as C-H bonds, resulting in a change of their scattering cross sections. This could 
be a reason responsible for the peak intensity decrease of 1342 cm−1. Furthermore, ROS is 
able to induce protein degradation, which may also be a cause for the intensity decline of the 
peaks at 1003, 1342, and 1659 cm−1. It should be pointed out that given the diversity of 
cellular components and the complexity of molecular interactions, the above discussion is 
only preliminary and the further investigation is needed. 
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6. Conclusions 
In this study, we have shown that the relative intensity of Raman peaks at 1342, 877, and 744 
cm−1, which correspond respectively to C-H deformation in proteins, C–C symmetric 
stretching in lipids, and C=O out-of-the-plane bending in Thymine, are highly sensitive to 
the changes of hUC-MSCs viability. The intensity decrease of the peak at 1342 cm−1 and the 
intensity enhancement of the peaks at 877 and 744 cm−1 in the cells with low viability are 
related to the alterations of the secondary structures of proteins, the degradation of proteins, 
the structural modification of lipids, and the destruction of base-base stacking interactions in 
DNA. These changes could be understood by the interactions between the excessive 
intracellular ROS and the biomolecules. 
 
 
 
 
 
 
 
 
Fig. 4. Averaged Raman spectra from 22 hUC-MSCs with high viability (curve “a”) and from 
20 cells with low viability (curve “b”). Shaded areas represent the standard deviations. The 
spectra were normalized to the intensity at 1448 cm−1. Difference spectrum (curve “c”) was 
obtained by subtracting curve “a” from curve “b”. Spectra are shifted vertically for clarity. 
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Fig. 5. Peak fitting of the averaged Raman spectra of hUC-MSCs with high viability (a) and 
low viability (b) in the spectral regions: 617 – 690, 703 – 770, 840 – 945, 950 – 1020, and 1190 – 
1375 cm−1. Empty circles – experimental data, thin lines – fitted peaks, and thick lines – fitted 
curves. 
 
 
Fig. 6. Comparison of relative intensities of Raman peaks between hUC-MSCs with high and 
low viability. Block – averaged relative intensity, Bar – standard deviation. * means p<0.05, 
** means p<0.001 obtained by the Student’s t-test analysis. 
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Raman shift 
(cm-1) 
Assignment [11,19,20,22-25] 
621 A 5-member ring deformation 
643 T ring angle bend 
667 G ring breath 
719 CN+(CH3)3 str in lipids 
732 A ring breath 
744 T C=O out of plane bend 
758 Trp ring breath 
784 O-P-O str of DNA 
811 O-P-O str of RNA 
827 Tyr out of plane ring breath  
853 Tyr ring breath 
877 C-C symm str in lipids 
900 deoxyribose 
934 C-C bk str in proteins 
980 =CH bend in lipids 
1003 Phe symm ring breath 
1010 C-O str in deoxyribose 
1031 Phe 
1064 Chain C-C str in lipids 
1083 C-N str in proteins; Chain C-C str in lipids; C-O str in carbohydrates 
1097 O-P-O- str 
1127 C-N,C-C str in proteins 
1157 C-C,C-N str in proteins 
1174 Tyr,Phe 
1209 C-C6H5 str of Phe 
1231 Amide III random coil 
1242 Amide III β-sheet 
1258 Amide III β-sheet 
1284 Amide III α-helix 
1301 CH2 twist in lipids 
1320 G; CH def in proteins 
1342 CH def in proteins 
1364 CH3 symm str in lipids 
1448 CH def in DNA/RNA, proteins, lipids and carbohydrates 
1659 Amide I α-helix 
Abbreviations: asym, asymmetric; symm, symmetric; str, stretching; def, deformation; bk, backbone; A, 
Adenine; G, Guanine; C, Cytosine; T, Thymine; U, Uracil; Phe: phenylalanine; Tyr: tyrosine; Trp: 
tryptophan. 
Table 1. Peak assignments for Raman spectra of hUC-MSCs 
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Region (cm-1) Wavenumber (cm-1) t-test p value 
617-690 
621 0.0215 * 
643 0.0026 * 
667 0.0024 * 
703-770 
719 0.0122 * 
732 0.2833 
744 0.0004 ** 
758 0.1163 
840-945 
853 0.0101 * 
877 0.0005 ** 
900 0.0145 * 
934 0.4063 
950-1020 
980 0.0173 * 
1003 0.0137 * 
1010 0.0166 * 
1190-1375 
1209 0.9462 
1231 0.1886 
1242 0.3941 
1258 0.2832 
1284 0.3884 
1301 0.0722 
1320 0.3496 
1342 0.0004 ** 
1364 0.6455 
 1659 0.0073 * 
*: p<0.05 means significant differences; **: p<0.001 means very significant differences. 
Table 2. p values obtained by the statistical intensity comparison of the peaks in the region 
617-690, 703-770, 840-945, 950-1020, 1190-1375 cm-1, and the peak at 1659 cm-1 between hUC-
MSCs with high and low viability. 
7. Relations between Reactive Oxygen Species and Raman Spectral 
Variations of Human Umbilical Cord Mesenchymal Stem Cells with Different 
Viability 
Mesenchymal stem cells (MSCs) are particularly attractive in cell-based therapy because of 
their distinct immunosuppressive properties and multi-differentiation capacity [27,28]. MSCs 
are traditionally found in the bone marrow. However, they can also be isolated from other 
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tissues such as human umbilical cord. Human umbilical cord-derived MSCs (hUC-MSCs) 
have shown similar or even superior properties compared to bone marrow derived MSCs 
(BM-MSCs) including plastic adherence, specific surface markers, regenerative  capability, 
collection convenience, safety, and potential of in vitro differential in certain lineages [29,30]. 
As a result of these advantages, hUC-MSCs have gained more attention in recent years. 
Currently, hUC-MSCs are being explored as a promising candidate for therapeutic 
applications. Wu and Zhou [31,32] discussed the therapeutic potential of hUC-MSCs in 
cardiomyocyte regeneration, and their findings demonstrated that transplanted hUC-MSCs 
provide benefit in the restoration of cardiac function, suggesting that hUC-MSCs represent a 
source of stem cells for cell therapy and myocardial tissue engineering. Liao et al. reported 
that hUC-MSCs treatment could be an ideal strategy for cell-based therapy for central 
nervous system injury and disease [7]. Moreover, the impact of hUC-MSCs on liver fibrosis 
was also observed by Han and co-workers [33]. Recently, a series of experimental results 
indicate that hUC-MSCs are exceptional candidates for muscle repair [30], bone tissue 
engineering [34] and the treatment of rheumatoid arthritis (RA) [35]. 
The above data indicate that the hUC-MSCs hold great promise as therapeutic agents and as 
a tool for understanding the development of regeneration medicine. It is known that a large 
population of cells with high viability is fundamental to a successful cell-based therapy. 
Therefore, the detection of cell viability changes represents a key step for the population 
expansion and quality assurance of hUC-MSCs. As a label-free method, Raman 
spectroscopy is increasingly used in the study of stem cells [10, 19-21]. In our recently work 
[36], this technology was used to detect the viability transitions of hUC-MSCs. An 
encouraging finding was that the most significant Raman spectral variations associated with 
the cell viability decrease were at 1342, 877, and 744 cm−1, which implied a great potential 
for characterizing the cell viability changes. Considering the biochemical effects involved in 
the reactions of reactive oxygen species (ROS) [26], we concluded that these Raman spectral 
changes are probably due to the interaction between the intracellular ROS and biological 
macromolecules. However, given the diversity of cellular components and the complexity of 
molecular interactions, the reasons and the mechanisms of the Raman spectral variations 
remain unclear. In this context, several studies in our group are being carried out with the 
purpose of providing insights into the role of ROS involved in the cell viability transitions. 
As an important aspect, the dependence of the Raman spectral variations on the yield of 
ROS in the cells has been studied in this paper. Here, we employ a ROS probe (DCFH-DA) 
to monitor the change of intracellular ROS level in hUC-MSCs as their viability declines. In 
addition, the Raman spectra of the cells with different viability are also recorded by Raman 
micro-spectroscopy. The results show that as the cell viability declines, the relative intensity 
variations of Raman peaks at 1342, 877, and 744 cm−1, and the relative yield variation of ROS 
in cells can be described by a same model(with different fitting parameters). Moreover, the 
correlations of these relative changes were evaluated by correlation coefficient method. It is 
found that they have perfect linear correlation coefficients respectively. This study further 
demonstrates that the relative yield variation of the ROS in hUC-MSCs with different 
viability can directly cause the relative intensity variation of Raman spectra in the cells. 
7.1 Intracellular ROS measurement 
The relative levels of ROS in hUC-MSCs with different viability were accessed using 2',7'-
dichlorofluorescin diacetate (DCFH-DA, Sigma), a fluorescent probe for intracellular ROS 
measurement. The DCFH-DA itself is non-fluorescent. It can be easily diffused through the 
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cell membrane and be hydrolyzed by intracellular esterases to produce non-fluorescent 2',7'-
dichlorofluorescin (DCFH), which can no longer pass through the membrane so that the 
probe can easily be loaded into the cells. DCFH is then oxidized by ROS to generate 
fluorescent 2',7'-dichlorofluorescein (DCF), whose fluorescence intensity is proportional to 
the amount of intracellular ROS [37, 38]. The cells were suspended in PBS at a density of 5.5 
× 105 cells/mL. After DCFH-DA was suspended at a final concentration of 20Ǎmol/L, the 
cells were incubated for 40 min at 37°C for probe loading. -DCF fluorescence was then 
measured by a spectrometer (SpectraPro 300i, Acton, USA) equipped with a CCD detector 
(Spec-10, PI, USA). Ar+ laser (488 nm) was used for excitation, and the fluorescence was 
recorded in the range of 510–600 nm. In addition, same measurements of the DCFH-DA and 
PBS mixture (final concentration of the probe: 20 Ǎmol/L) without cells for fluorescent 
background acquisition were also performed. 
7.2 Experimental results  
ROS consist of a series of oxygen free radicals and their derivatives, such as O2-, H2O2, and 
OH, possess active chemical properties and high oxidation capability. They are generated 
from the sequential univalent reduction of oxygen involved in the cell metabolism [39, 40]. 
Since the cell itself has a highly efficient antioxidant system for eliminating ROS, the 
production and scavenging of ROS maintain a dynamic equilibrium under normal 
conditions. An appropriate amount of ROS is associated with many important physiological 
functions, such as biological messengers involved in cellular signal transduction [41, 42]. 
However, the production of intracellular ROS will greatly exceed the cellular antioxidant 
capacity under oxidative stress [43]. And ROS can act as the toxicants that easily react with 
biomolecules to damage their structures and functions and change their physical and 
chemical properties as Raman scattering [43–45]. 
Thus, to explore whether ROS play a role in the Raman spectral variations associated with 
the hUC-MSCs’ viability transitions, we first monitored the change of intracellular ROS level 
as the cell viability decreased. As shown in Fig. 7, under the condition of cell starvation, the 
cell viability exhibits a linear decline with time. Therefore, the changes of the ROS level and 
the Raman spectra in cells as the cell viability decreases can be measured and discussed in 
the time dimension. By using ROS probe (DCFH-DA), the intracellular ROS levels were 
observed by the fluorescence spectra of the probe at different times. The results are shown in 
Fig. 8. The fluorescence spectra are from DCF, which is produced by the reactions of the 
probes with ROS. No fluorescence signals can be detected in the mixture solution of the 
probe molecules and PBS without the cells (“Background” in Fig. 8A), indicating that the 
fluorescence is originated only from the interaction of the probes with the intracellular ROS 
but not self-oxidation of the probes. Therefore, the relative intensities (F) of the fluorescence 
in Fig. 8A will be directly proportional to the ROS level (ROS) in cells [37, 38] under the 
experimental conditions we designed. The relationship can be expressed as follows 
 F ROS= ε  (1) 
where ε is the proportional constant in this case. Fig. 8B shows the column diagram of the 
relative fluorescence intensity at different times based on Fig. 8A. It is apparent that as the 
viability decreases, the level of ROS increases initially. It reaches a maximum value about 1.5 
times higher than the initial time (t = 0) as the viability drops to about 36%. As the viability 
continues to decrease, the ROS level experiences a decline. 
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As mentioned above, a low ROS level under normal conditions is beneficial to the cells. Few 
oxidative damages by ROS should be taken into consideration in this case. However, when 
the production of ROS exceeds the cellular antioxidant capacity, oxidative damages will 
occur [39]. In other words, the excessive intracellular ROS lead to the oxidative damages. 
Considering this, we calculate the relative variation of ROS level (ΔROS(t)) in the cells at 
each measurement time t based on the data in Fig. 8B, and take the first relative intensity at 
initial time (t = 0) as a normal value in the cells with normal viability. Therefore, the ΔROS(t) 
(t is the measurement time in Fig. 8B) can be calculated by the following expression. 
 
( ) (0)
( ) 100%
(0)
F t F
ROS t
F
−Δ = ×  (2) 
where F(t) and F(0) represent the relative fluorescence intensity at time t and the initial time 
(t = 0), respectively. The change of ΔROS with time is shown by the black squares in Fig. 9. 
Based on the data shown in Fig. 9, we seek to find a mathematical model to describe their 
change with time. It is found that a rational function (shown in Eq. (3)) can make a good 
fitting with the fitting degree R2 = 0.983. Thus, the ΔROS(t) can generally be expressed by 
the rational function as follows. 
 
2
( )
1
a bt
ROS t
ct dt
+Δ = + +  (3) 
The data in Fig. 9 show that the ROS level is always higher than the initial (t = 0) in our 
observation period, implying that an accumulation of the excessive ROS in cells may occur 
as the cell viability decreases. 
It should be noted that according to our experimental methods, the DCF fluorescence 
intensity is proportional to the amount of ROS generated in a short time period (40 min), 
which can be considered as a time point when compared to the entire experimental period 
(7 days). Thus, the data presented in Fig. 9 can only show the variation of “transient” ROS 
level, but not the yield of ROS during the cell viability decline. Since the oxidative damages 
resulting from excessive ROS can be irreversible [42], they thus rely on the cumulative effect 
of excessive ROS reacting with biomolecules. This means that the oxidative damages 
depend in part on the yield variation of ROS as the cell viability decreases. Having this in 
mind, we estimate the relative yield variation of ROS by integrating Eq. (3).  
 
20
( )
1
ct
yield c
a bt
ROS t dt
ct dt
+Δ = + +∫  (4) 
And thus 
 2
2 2
2 2 1
arctan ln
24 4
ad bc dt c b c
t t
d d dd d c d c
⎛ ⎞− + ⎛ ⎞= + + +⎜ ⎟ ⎜ ⎟⎜ ⎟ ⎝ ⎠− −⎝ ⎠
 (5) 
Calling the values of the parameters (a, b, c, d) from the best fitting result in Fig. 9 and 
considering the integral upper and lower limits, we can estimate the relative yield variation 
of ROS at any time point. The estimated ΔROSyield(t) at t = 0d, 1d, 2d, …, 6d is shown in Fig. 
10, which exhibits a nonlinear increase with time. In particular, it is found that the change of 
ΔROSyield(t) can be exactly described by the logistic model (Eq. (6)) as indicated by the fitting 
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degree R2 = 0.999. This model describes an S-type growth, i.e., the growth gradually slows 
down and eventually stops when the time goes to infinity. 
 ( )
1 t
f t
e−γ
α= + β  (6) 
The above results show that the relative yield variation of intracellular ROS increases 
continuously with the cell viability drop, suggesting that excessive ROS accumulate in cells 
and thus may attack the biomolecules as expected. 
The excessive ROS are capable of attacking biomolecules, such as proteins, nucleic acids, 
and lipids, by a variety of reaction mechanisms including hydrogen abstraction, addition, 
etc. [40, 46, 47]. For example, ROS can react directly with the amino acid residues, causing 
the inactivation and denaturation of proteins [46]. Their attacks on DNA can also lead to the 
DNA bases modification and breaking of chemical bonds and certain strands [39, 47]. In 
addition, ROS induce the peroxidation of unsaturated fatty acids and cause oxidative 
damage to lipids [39, 40]. This reaction is also an important mechanism that occurs with the 
oxidative damage to other biomolecules, such as malondialdehyde, an intermediate of 
peroxidation, that can cause the cross-linking of proteins [40, 46]. The oxidative damages 
from these reactions will undoubtedly lead to the structural and functional alterations of the 
biomolecules, and thus may cause changes in their Raman scattering. 
Here we will pay attention to the dependence of the Raman spectral changes on ROS, but 
not the types of oxidative reactions that lead to the changes. That is, the relationship 
between Raman spectral variations and the relative yield variation of ROS in the cells need 
to be examined further in this paper. Raman spectra of hUC-MSCs with different viability 
(or at different time points) are shown in Fig. 11A. Raman spectral variations as the cell 
viability declines can be observed clearly. Thus we choose three vibration peaks that have 
been proven to be sensitive to the hUC-MSCs viability transitions [35]. They are protein C-H 
deformation at 1342 cm–1, lipid C–C symmetric stretching at 877 cm–1, and thymine C=O 
out-of-the-plane bending at 744 cm–1. Their relative intensity changes as a function of time 
are shown in Fig. 11B. It can be seen that the relative intensity of 1342 cm–1 decreases with 
time, while those of 877 and 744 cm–1 exhibit the reverse orientation. Further, we will focus 
on the variation of the relative intensity, because any deviations of these characteristic peak 
intensities from their normal values will indicate the drop of cell viability [35].   
Based on the data shown in Fig. 11b and the above method used to discuss ROS (Eq. (2)), the 
relative peak intensity variations (ΔIw(t)) of the three peaks can be calculated by the 
following expression. 
 
( ) (0)
( ) 100%
(0)
w w
w
w
I t I
I t
I
−Δ = ×  (7) 
where Iw(t) and Iw(0) represent the relative intensity of the peak w at the time t and the 
initial time (t = 0), respectively. The calculated results are shown in Fig. 12. 
To investigate the change tracks of ΔI1342(t), ΔI877(t), ΔI744(t) and their relationship to 
ΔROSyield(t), we also try to use the logistic model (Eq. (6)) to fit the data points in Fig.12. As 
presented in Fig. 12, it is interesting to find that the logistic model is also suitable for 
describing the changes of ΔI1342(t), ΔI877(t), and ΔI744(t) indicated by the high fitting degrees 
of 0.993, 0.986, and 0.996, respectively. However, the parameters (ǂ, ǃ, Ǆ) obtained by fitting 
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ΔI1342(t), ΔI877(t), and ΔI744(t) differ from each other, and also show large differences from 
those of fitting ΔROSyield(t). This seems reasonable and understandable from the complexity 
and diversity of ROS reactions. There are many mechanisms showing that ROS interact with 
biomolecules directly or indirectly [40, 46, 47]. The attack of ROS seems impossible to cause 
the synchronous and homogeneous alterations in all the biomolecules. The differences in the 
molecular response (rate, scale, sensitivity) to the ROS attack and the types of reactions will 
inevitably affect the reaction rates (of the reactant depletion and the product formation) in 
the cells. And also, the formation of the excessive ROS themselves will lead to the 
component changes in the cells. All complications make the fitting parameters or the fitting 
curves of ΔIw(t) of some individual Raman peaks w show larger deviation from those of 
ΔROSyield(t). That is, it is almost impossible for all ΔIw(t) to correlate with ΔROSyield(t) in 
exact linearity. Furthermore, it should be mentioned that the parameter ǂ is primarily 
determined by the maximum of the relative intensity (or yield) variation and is basically 
independent on the fitting curves that is defined by the shape parameters ǃ and Ǆ. The 
differences between ΔI744(t) and ΔROSyield(t) in the two shape parameters are the largest (Fig. 
12C) in all the ΔIw(t), thus the linear correlation between their fitting curves is the lowest, 
suggesting that the reaction mechanism relating to this peak increase would be very 
complicated. In fact, the ROS in the cells are consumed through many channels. Therefore, 
we may have a better result if using the sum of the relative intensity variations of all 
characteristic Raman peaks (here we have three peaks) measured at the same time. The 
relative intensity total variation as a function of time (ΔItotal(t)) is expressed as follows. 
 ( ) ( )total w
w
I t I tΔ = Δ∑  (8) 
where ΔIw(t) is the relative intensity variation of the peak w at time t. Here we have w = 
1342, 877, and 744 cm–1. The calculated results are shown in Fig. 12d, and the fitting curve 
(with Eq. (6)) shows a perfect fitting degree (R2 = 0.999). All the fitting constants for ΔItotal(t) 
are much better than those for any other ΔIw(t) compared with those for ΔROSyield(t). Thus, 
the fitting curves of ΔItotal(t) and ΔROSyield(t) are basically similar, and the linear relationship 
between them should be better than others. 
To further quantitatively evaluate the relationship, the correlation coefficient r is employed 
to describe the correlations of ΔI1342(t), ΔI877(t), ΔI744(t), and ΔItotal(t) with ΔROSyield(t), 
respectively. The r is calculated as follows [48].  
 1
2 2
1 1
( )( )
( ) ( )
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i i
i
n n
i i
i i
X X Y Y
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X X Y Y
=
= =
− −
=
− × −
∑
∑ ∑
 (9) 
where, Xi, Yi (i = 1, 2, …, n) express independent and dependent variables respectively; r 
describes the linear correlation of the two variables and takes the value in –1 ≤ r ≤ 1. The 
larger |r| is, the higher the correlation will be. The calculation results show that the 
correlation coefficients for correlated ΔI1342(t), ΔI877(t), ΔI744(t), and ΔItotal(t) to ΔROSyield(t) are 
0.980, 0.985, 0.973, and 0.987, respectively. For clarity, these correlations are shown in Fig. 
13. The high |rw| values provide a further evidence to confirm that the changes of the three 
relative peak intensities linearly correlate to the relative yield variation of ROS, especially at 
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the beginning of the cell viability decrease. Taken together, the results demonstrate that the 
oxidative damages induced by excessive intracellular ROS lead to the Raman spectral 
variations associated with the cell viability decline. In addition, the ΔItotal(t) shows the best 
linear relationship to the ΔROSyield(t), while that of individual Raman peak intensity appears 
lower linear correlation coefficient, indicating that the corresponding biochemical reactions 
of intracellular ROS have much more complicate mechanisms and needs further study. 
8. Conclusions 
Herein, we reveal that the relative yield variation of ROS in hUC-MSCs with different 
viability can directly lead to the relative intensity variations of the three characteristic 
Raman peaks at 1342, 877, and 744 cm–1 in the cells, according to their perfect linear 
correlation coefficients of 0.980, 0.985, and 0.973, respectively. Our findings demonstrate that 
the excessive intracellular ROS can result in the almost linear variation of the relative Raman 
peak intensity in hUC-MSCs as the cell viability declines. These results would be very useful 
for understanding the mechanisms of Raman spectral changes in the cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. Change of cell viability as a function of time (cells are placed under starvation 
condition). The line represents the linear fitting. 
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Fig. 8. Change of intracellular ROS level with time. (A) Fluorescence spectra of DCF at 
different times corresponding to different cell viability. (B) Histogram showing averaged 
relative intensities of DCF fluorescence and standard deviation. 
 
 
 
 
 
 
 
 
 
Fig. 9. Relative variation of ROS level as a function of time. The data points are from Eq. (2). 
The line represents the best fitting using a rational function (Eq. (3)), with the fitting degree 
R2 = 0.983 and the parameters a = –0.80747, b = 6.77836, c = –0.50330, d = 0.07387. 
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Fig. 10. Change of relative yield variation of ROS as a function of time. The line represents 
the best fitting using logistic model (Eq. (6)), with the fitting degree R2 = 0.999 and the 
parameters ǂ = 494.247, ǃ = 208.473, Ǆ = 1.35624. 
 
 
 
 
 
 
 
Fig. 11. (A) Raman spectra of hUC-MSCs with different cell viability: (a) cell viability 97%, t 
= 0 (b) 67%, t = 2d (c) 36%, t = 4d (d) 22%, t = 5d (e) 2%, t = 6d. All spectra are normalized to 
the peak intensity at 1448 cm–1. Spectra are shifted vertically for clarity. (B) Changes of the 
relative peak intensities at 1342, 877, and 744 cm–1 as a function of time. 
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Fig. 12. Relative changes of Raman peak intensity variations at (A) 1342, (B) 877, (C) 744 cm–1, 
and their sum (D) as a function of time. The lines represent the best fitting using logistic 
model (Eq. (6)). (A) Fitting degree R2 = 0.993, the parameters ǂ = 91.3853, ǃ = 58.5466, Ǆ = 
0.67544. (B) R2 = 0.986, ǂ = 216.993, ǃ = 62.1816, Ǆ = 0.78485. (C) R2 = 0.996, ǂ = 154.484, ǃ = 
5191.54, Ǆ = 1.95969. (D) R2 = 0.999, ǂ = 430.957, ǃ = 122.328, Ǆ = 1.00860. 
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Fig. 13. Correlations between the relative yield variation of ROS and the relative intensity 
variations of Raman peaks at (A) 1342, (B) 877, (C) 744 cm–1 and their sum (D) ΔItotal(t). The 
lines represent the linear fittings for the changes of ΔI1342(t), ΔI877(t), ΔI744(t), and ΔItotal(t) as a 
function of ΔROSyield(t), with the correlation coefficients of 0.980, 0.985, 0.973, and 0.987, 
respectively. 
9. Summary 
Mesenchymal stem cells (MSCs) are pluripotent progenitor cells derived from the 
mesoderm. They are particularly suitable for cell-based therapy because of their different 
immunosuppressive properties and multi-differentiation capacity. The main source of MSCs 
is bone marrow. In addition, recent progress revealed that human umbilical cord derived 
mesenchymal stem cells (hUC-MSCs) could be an alternative source ideal for MSCs. 
Comparing to bone marrow-derived MSCs (BM-MSCs), hUC-MSCs have exhibited similar 
or even superior properties such as plastic adherence, specific surface markers, regenerative 
capability, collection convenience, safety, and potential for in vitro differential in certain 
lineages. These advantages make hUC-MSCs a promising candidate for therapeutic 
applications in recent years.  
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As is known, a large population of cells in sustained high profitability is fundamental to 
successful cell-based therapy. Therefore, monitoring the variation in cell viability is an 
important step for the population expansion and quality assurance of hUC-MSCs. Right 
now there are a number of methods including biological assays and optical techniques 
available to handle this task. Among these techniques, Raman spectroscopy is a label-free 
method that allows for continued analysis. Moreover, it is proven that Raman spectroscopy 
has the potential to offer new and unique optical markers for cytological analysis. Currently 
this technology is increasingly used in the studies of stem cells.  
In this work, Raman micro-spectroscopy is used to monitor the variation of hUC-MSCs 
viability. The Raman spectra of hUC-MSCs with different cellular states are investigated. 
Using peak fitting and statistical t-test, the Raman peaks are extracted with obvious 
differences between cells of different viability. Most significant changes (p <0.001) have been 
found for the out-of-plane bending of C=O in thymine at 744cm-1, symmetric stretching of 
C-C in lipids at 877cm-1, and deformation of C-H in proteins at 1342cm-1. As the cell viability 
decreases, the intensity of the peak at 1342cm-1 is reduced, whereas those of the peaks at 877 
and 744 cm-1 are enhanced. Based on these results, we propose that the viability of hUC-
MSCs can be characterized by these three peaks.  
Given the biochemical effects involved in the reactions of reactive oxygen species (ROS), we 
conclude that the changes of Raman peak intensity could be explained by the interactions 
between excessive intracellular ROS and biological macromolecules. However, considering 
the diversity of cellular components and the complexity of molecular interactions, the exact 
reasons and mechanisms remain unclear. In this context, we further investigate the 
dependence of the Raman spectral variations on the yield of ROS in the cells for 
understanding the mechanism. Here we employ a ROS probe (DCFH-DA) to monitor the 
change of intracellular ROS level in hUC-MSCs as their viability declines. The results we 
obtained show that as the cell viability decreases, the relative intensity variations of the 
Raman peaks at 1342 cm-1, 877 cm-1, and 744 cm-1, and the relative yield variations of ROS in 
cells can be described by the same model function (besides different fitting parameters 
used). In addition, the correlations of these relative changes were assessed by correlation 
coefficient method. Perfect linear correlation coefficients of 0.969, 0.982, and 0.975 were 
found. Our results further demonstrate that the relative yield variations of ROS in hUC-
MSCs with different viability directly cause the relative intensity variations of Raman 
spectra in the cells. The results would be very useful for understanding the mechanism of 
the Raman spectral changes in the cells and the investigation of the basis for the application 
of Raman scattering in the measurement of stem cell viability. 
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